Boston Financial & Equity Corporation (BFEC) recently funded an equipment lease for a Vaccine platform and development company. The company was originally funded by two strategic corporate investors, and its most recent round, $22 million by an international investment company.  The company is still pre-clinical, and currently burns close to $1 million a month. The company focuses on site specific conjugation, developing novel vaccines for an array of diseases. Conjugate Vaccines comprise the largest segment, $8 billion,  of the vaccine industry. The company is leasing HPLC Lab equipment.

BFEC also recently funded, a lease for $150,000 of furniture and workstations, for a six-year old digital publisher an multimedia content company. They provide digitization and distribution services for authors and small independent publishers. Although revenue generating, they are still not profitable but were able to increase their current bank line and secure an additional $4 million in equity from their current investors.